Generative AI in Life Sciences: Medical & Commercial Transformations
Guest - Indy Sawhney, AI/ML Strategy & Adoption Acceleration Lead, US Commercial Sales, HCLS | AWS
Host - Jane Urban, Chief Data & Analytics Officer, Improzo
Date : October 15, 2025
Time : 37 min
About the Episode
Welcome back to the ImproZone Podcast. In this episode, our very own Jane Urban is in conversation with Indy Sawhney from AWS about how artificial intelligence (AI), particularly generative and agentic AI, is changing the life sciences. Indy offers practical examples of how AI can enhance human performance rather than replace it, from expediting drug discovery to improving patient care through smarter, more individualized treatments. Together, they explore the challenges, opportunities, and unexpected ways AI is transforming the sector while keeping human input central to every decision. It’s a discussion brimming with ideas, useful advice, and a glimpse into the future of healthcare.
Highlights from the Episode:
- The complexity of healthcare and life sciences, and how AI can enhance human performance while respecting expertise.
- The importance of “human at the front of Gen AI”—asking the right questions to get actionable results.
- How generative AI is enabling faster, smarter insights across global biopharma operations.
- Phase-wise adoption strategies: starting with internal use cases to safely experiment, learn, and scale AI.
- Indy’s advice: focus on execution over strategy, aligning AI with existing business goals for real impact.
One Quote to Remember:
“You don’t need an AI strategy—you need an execution plan. AI is just the tool; what matters is how you use it to achieve your business goals.”
Recommended content
About the Authors
Jane Urban
Chief Data & Analytics Officer
Indy Sawhney
AI/ML Strategy & Adoption Acceleration Lead, US Commercial Sales, HCLS | Amazon Web Services